Guardant Health Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Revenue Outlook for Full Year 2021

Go back to Guardant Health Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Revenue Outlook for Full Year 2021

Guardant Health (GH) Misses Q4 EPS by 37c

February 24, 2021 4:46 PM EST

Guardant Health (NASDAQ: GH) reported Q4 EPS of ($0.94), $0.37 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $78.3 million versus the consensus estimate of $76.73 million.

GUIDANCE:

Guardant Health sees FY2021 revenue of $360-370 million, versus the consensus of... More